Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Hata

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Science Advances|August 19, 2021
Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severityZintis Inde, Ben A Croker, Clarence Yapp, et al.
Cancer Discovery|February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIMKyung-A Song, Matthew J Niederst, Timothy L Lochmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancerAnthony C Faber, Anna F Farago, Carlotta Costa, et al.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
Cancer Research|July 2, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast CancerDejan Juric, Kazi N Islam, Ioanna-Maria Gkotinakou, et al.
Science (New York, N.Y.)|June 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interactionDhirendra K Simanshu, Rui Xu, James P Stice, et al.
Nature|July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cellsHideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Science Advances|August 19, 2021
Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severityZintis Inde, Ben A Croker, Clarence Yapp, et al.
Cancer Discovery|February 28, 2018
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J Drapkin, Julie George, Camilla L Christensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
Epithelial-to-Mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer by Suppressing BIMKyung-A Song, Matthew J Niederst, Timothy L Lochmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2015
Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancerAnthony C Faber, Anna F Farago, Carlotta Costa, et al.
Cancer Cell|February 10, 2016
Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationJungoh Ham, Carlotta Costa, Renata Sano, et al.
Cancer Research|July 2, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast CancerDejan Juric, Kazi N Islam, Ioanna-Maria Gkotinakou, et al.
Science (New York, N.Y.)|June 12, 2025
BBO-10203 inhibits tumor growth without inducing hyperglycemia by blocking RAS-PI3Kα interactionDhirendra K Simanshu, Rui Xu, James P Stice, et al.
Nature|July 5, 2023
Therapy-induced APOBEC3A drives evolution of persistent cancer cellsHideko Isozaki, Ramin Sakhtemani, Ammal Abbasi, et al.
Nature Medicine|October 21, 2023
Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Nature Medicine|December 4, 2023
Author Correction: Liquid biopsy epigenomic profiling for cancer subtypingSylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, et al.
Pageof 27